GlassScriptPhysician profile
Srishti Nayak
NPI 1487186813
$2,375.70
in general payments reported to CMS, 2019-2025
12 companies · $572 in 2025
The $572 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $250 · 2022: $453 · 2023: $653 · 2024: $448 · 2025: $572.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,673.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,673.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $769.53 | 2021-2024 | Lifevest |
| Boston Scientific Corporation | $313.46 | 2023-2025 | Accolade Sr |
| Edwards Lifesciences Corporation | $295.26 | 2021-2022 | |
| W. L. Gore & Associates, INC. | $182.36 | 2022-2025 | Gore Excluder Thoracoabdominal Branch Endoprosthesis |
| Abbott Laboratories | $144.35 | 2025 | Thoratec Heartmate 3 Lvas Implant Kit |
| Novartis Pharmaceuticals Corporation | $131.23 | 2024 | |
| Impulse Dynamics (USA) INC. | $122.18 | 2023 | Optimizer |
| Novo Nordisk INC | $112.47 | 2024 | Wegovy |
| Amgen INC. | $107.32 | 2025 | Repatha |
| Abiomed | $82.60 | 2025 | |
| Medtronic, INC. | $66.67 | 2022 | |
| Zoll Circulation INC | $48.27 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Srishti Nayak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.